Literature DB >> 29765967

Nail Pyogenic Granuloma following Treatment with Blinatumomab.

Dilshad Paurobally1, Josette Andre2, Bertrand Richert2.   

Abstract

Entities:  

Year:  2017        PMID: 29765967      PMCID: PMC5939719          DOI: 10.1159/000479575

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


× No keyword cloud information.
  10 in total

1.  Pyogenic granuloma-like lesion associated with topical tazarotene therapy.

Authors:  M A Dawkins; A R Clark; S R Feldman
Journal:  J Am Acad Dermatol       Date:  2000-07       Impact factor: 11.527

2.  Paronychia associated with antiretroviral therapy.

Authors:  A Tosti; B M Piraccini; A D'Antuono; S Marzaduri; V Bettoli
Journal:  Br J Dermatol       Date:  1999-06       Impact factor: 9.302

Review 3.  Periungual and subungual pyogenic granuloma.

Authors:  B M Piraccini; S Bellavista; C Misciali; A Tosti; D de Berker; B Richert
Journal:  Br J Dermatol       Date:  2010-11       Impact factor: 9.302

4.  Drug-related nail disease.

Authors:  Bianca Maria Piraccini; Aurora Alessandrini
Journal:  Clin Dermatol       Date:  2013 Sep-Oct       Impact factor: 3.541

5.  Multiple eruptive periungual pyogenic granulomas during anti-CD20 monoclonal antibody therapy for rheumatoid arthritis.

Authors:  Uwe Wollina
Journal:  J Dermatol Case Rep       Date:  2010-12-19

6.  Paronychia and pyogenic granuloma induced by new anticancer mTOR inhibitors.

Authors:  Vincent Sibaud; Florence Dalenc; Loic Mourey; Christine Chevreau
Journal:  Acta Derm Venereol       Date:  2011-09       Impact factor: 4.437

7.  [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].

Authors:  B Bégaud; J C Evreux; J Jouglard; G Lagier
Journal:  Therapie       Date:  1985 Mar-Apr       Impact factor: 2.070

Review 8.  Nail toxicity induced by cancer chemotherapy.

Authors:  Peter Gilbar; Alice Hain; Veta-Marie Peereboom
Journal:  J Oncol Pharm Pract       Date:  2009-01-26       Impact factor: 1.809

9.  Pyogenic granulomas following topical application of tretinoin.

Authors:  A Teknetzis; D Ioannides; G Vakali; I Lefaki; A Minas
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-05       Impact factor: 6.166

Review 10.  A review of blinatumomab, a novel immunotherapy.

Authors:  Matthew J Newman; Dina J Benani
Journal:  J Oncol Pharm Pract       Date:  2015-11-24       Impact factor: 1.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.